Analysis of the incidence of HIV infection in the Altai region in 2022
https://doi.org/10.1234/10.25789/YMJ.2024.88.19
Abstract
An analysis of epidemiological data is presented, indicating the continuation of changes in the structure of HIV-infected people in the Altai Territory, as in the Russian Federation as a whole (an increase in the proportion of the female population, the proportion of people over 30 years old, the dominance of the sexual transmission of infection). Low genetic diversity of HIV -1 was revealed. A high frequency of recombinant form of CRF63_02A6, as well as drug resistance to drugs of the first generation NNRTI class is recorded.
About the Authors
N. V. LukyanenkoRussian Federation
D. E. Kireev
Russian Federation
I. A. Lapovok
Russian Federation
A. A. Kirichenko
Russian Federation
A. V. Shlykova
Russian Federation
D. V. Fomina
Russian Federation
M. A. Asmanova
Russian Federation
V. V. Shevchenko
References
1. HIV infection in the Russian Federation in 2010: reference. - http://www.hivrussia.info/wp-content/uploads/2019/02/VICH-infektsiya-v-Rossijskoj-Federatsii-v-2010-g.pdf.
2. VICH-infektsiya-v-Rossijskoj-Federatsii-v-на 31 decabrya 2014 g. pdf HIV infection in the Russian Federation as of December 31, 2014: reference //Ibid.
3. HIV infection in the Russian Federation as of December 31, 2022: reference // Ibid.
4. H.I.V. is a viral infection. Clinical guidelines of the National Virological Association and the Mos cow Cancer Society, 2023.
5. Genetic analysis of HIV-1 in the Altai Terri tory: further spread of the CRF63_02A1 variant throughout Western Siberia / E.V. Kazennova, A.A. Antonova, E.N. Ozhmegova [et al.] // HIV in fection and immunosuppression. 2020. T. 12, No. 1. P. 47–57. DOI: http://dx.doi.org/10.22328/2077-9828-2020-12-1-47-57.
6. Genetic diversity of VICh-1 in the current stage of the epidemic in the Russian Federation: an in crease in the prevalence of recombinant forms / Antonova A.A., Kuznetsova A.I., Ozhmegova E.N. [et al.] //HIV infection and immunosuppres sion. 2023. Vol. 15, No. 3 P. 61–72. doi: http://dx.doi.org/10.22328/20779828-2023-15-3-61-72.
7. Genetic diversity and HIV-1 drug resis tance mutations in the Leningrad Region./ SHCHemelev A.N., Semenov A.V., Ostankova YU.V., Zueva E.B., Valutite D.E., Semenova D.A., Davydenko V.S., Totolyan A.A. // Journal of Mi crobiology, Epidemiology and Immunobiology. 2022;99(1):28–37.DOI: https://doi.org/10.36233/0372-9311-216
8. Kotova O.V., Balahonceva L.A., Trocenko O.E. Analysis of HIV -1 drug resistance in regions of the Far Eastern Federal District//HIV infection and immunosuppression. 2016. T. 8, No. 3. P. 53 58.
9. Molecular epidemiological analysis of VICh 1 variants circulating in Russia in 1987-2015. / Lapovok I.A., Lopatukhin A.E., Kireev D.E., [et al.] // Ter. archive 2017; 89(11): P. 44–9. DOI: 10.17116/terarkh2017891144-49.
10. Molecular epidemiological analysis of genetic variants of HIV-1 circulating in Eastern European and Central Asian countries in 2010-2019. / Lapo vok I.A., Kirichenko A.A., Shlykova A.V., [et al.] // Epidemiol. infectious. diseases. Actual. vopr. 2021; 12(3): P. 31–40;
11. E.N. Ozhmegova, M.R. Bobkova. Drug resis tance of HIV: previous and current trends. Ques tions of virology. 2022; 67(3): P. 193–205. DOI: https://doi.org/10.36233/0507-4088-113
12. Primary drug resistance among newly diag nosed HIV-1 patients in St. Petersburg. // Ingabire T., Semenov A.V., Esaulenko E.V., Zueva E.V., SHCHemelev A.N., Bushmanova A.D.// HIV infec tion and immunosuppression. 2021; 13(1):70-79. https://doi.org/10.22328/2077-9828-2021-13-1-70-79.
13. Polyakov A.N., Polyakova A.V., Saf'yanova T.V. Assessment of the epidemiological situation on the incidence of HIV infection in the Altai Terri tory in 2006-2014//Medical Review. Science and Practice, 2016, No. 1. P.12-15.
14. Prevalence of human immune deficiency virus infection in the territories of the Russian Feder ation in 2021. / Ladnaia N.N., Pokrovsky V.V., Sokolova E.V., Chekryzhova D.G., Kirzhanova V.V. // Epidemiol. Infect. Dis. Curr. Items, 2022, Vol. 12, P. 12–18;
15. Reshetnikov A.V., Pavlov S.V. Mod ern social portrait of HIV-infected Rus sia. Immunology. 2018; 39 (2-3): 100-107. DOI: http://dx.doi.org/10.18821/0206-4952-2018-39-2-3-100-107.
16. Baryshev P., Bogachev V., Gashnikova N. HIV-1 genetic diversity in Russia: CRF63_02A1, a new HIV type 1 genetic variant spreading in Si beria. AIDS Res. Hum. Retroviruses 2014; 30(6): 592–7. DOI: 10.1089/AID.2013.019;
17. Bobkova M. Current status of HIV-1 diver sity and drug resistance monitoring in the former USSR. AIDS Rev. 2013; 15(4): 204–12. PMID: 24192601
18. CRF63_02A6 sub-epidemic. / Siv ay M.V., Maksimenko L.V., Osipova I.P., et al. // Front. Microbiol. 13:946787. doi: 10.3389/fmicb.2022.946787;
19. Drug Resistance Mutations for Surveil lance of Transmitted HIV-1 Drug-Resistance: 2009 Update. / Bennett DE, Camacho RJ, Otelea D, et al. // PLoS ONE. 2009; 4:e4724.
20. HIV-1 Drug Resistance among Treat ment-Naïve Patients in Russia: Analysis of the National Database, 2006–2022. / Kirichenko, A. Kireev, D. Lapovok, I., et al. / HIV-1Viruses 2023, 15, 991. https://doi.org/10.3390/v15040991;
21. Primate immunodeficiency virus classifi cation and nomenclature: Review. / Foley B.T., Leitner T., Paraskevis D., Peeters M. // Infect. Genet. Evol. 2016; 46: 150–8. DOI: 10.1016/j.meegid.2016.10.018.
Review
For citations:
Lukyanenko N.V., Kireev D.E., Lapovok I.A., Kirichenko A.A., Shlykova A.V., Fomina D.V., Asmanova M.A., Shevchenko V.V. Analysis of the incidence of HIV infection in the Altai region in 2022. Yakut Medical Journal. 2024;(4):80-84. (In Russ.) https://doi.org/10.1234/10.25789/YMJ.2024.88.19